tetramethylpyrazine has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Lin, D; Lin, J; Lin, Z; Wang, P; Xu, J; Zhang, D; Zhou, C | 1 |
| Huang, XE; Ji, AJ; Ju, WZ; Liu, SL | 1 |
2 other study(ies) available for tetramethylpyrazine and Carcinoma
| Article | Year |
|---|---|
Tetramethylpyrazine-Rhein Derivative inhibits the migration of canine inflammatory mammary carcinoma cells by mitochondrial damage-mediated apoptosis and cadherins downregulation.
Topics: Animals; Apoptosis; Cadherins; Carcinoma; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dogs; Down-Regulation; Lung Neoplasms | 2023 |
Anti-proliferation effects and molecular mechanisms of action of tetramethypyrazine on human SGC-7901 gastric carcinoma cells.
Topics: Apoptosis; Blotting, Western; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Down-Regulation; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; NF-kappa B; Pyrazines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach Neoplasms; Up-Regulation | 2014 |